MDXG targets shortsellers on upcoming CC: https://finance.yahoo.com/news/mimedx-host-shareholder-call-september-200100474.html The subject matter, topics and updates to be covered during the formal presentation include: • Short Selling Matters and Proactive Remedies • Patent and Intellectual Property Matters • IND and BLA Clinical Studies • Biopharma Market Valuations and Revenue Opportunities • Additional Revenue Opportunity from VLU Clinical Study Companies who do this have a very bad collective track record.